HMS
FOLD

Hanseatic Management Services’s Amicus Therapeutics FOLD Stock Holding History

Hanseatic Management Services’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-60
Closed -$1K – 392
2018
Q2 		$1K Hold
60
– – ﹤0.01% 351
2018
Q1 		$1K Hold
60
– – ﹤0.01% 389
2017
Q4 		$1K Sell
60
-32
-35% -$440 ﹤0.01% 376
2017
Q3 		$1K Buy
+92
New +$1.22K ﹤0.01% 380
2015
Q4 		– Sell
-46,923
Closed -$656K – 335
2015
Q3 		$656K Buy
+46,923
New +$736K 0.2% 158

Other funds holding FOLD

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Hanseatic Management Services's FOLD Position: Q3 2018 in Review

Hanseatic Management Services sold out of Amicus Therapeutics (FOLD) in Q3 2018, closing a stake of 60 shares — an estimated $1K sold.

Hanseatic Management Services first reported a position in FOLD in Q3 2015 and held it in 5 quarters. The position peaked at $656K in Q3 2015. 204 funds tracked by Wall St. Rank hold FOLD as of Q3 2018.

  • Hanseatic Management Services reported no remaining Amicus Therapeutics position as of Q3 2018 after selling out during the quarter.
  • Hanseatic Management Services sold 60 Amicus Therapeutics shares in Q3 2018, an estimated $1K.
  • Hanseatic Management Services first reported a position in Amicus Therapeutics in Q3 2015 and held it in 5 quarters.
  • Hanseatic Management Services's Amicus Therapeutics position peaked at $656K in Q3 2015.
  • 204 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q3 2018.

Based on Hanseatic Management Services's 13F filing for Q3 2018, filed 14 Nov 2018.